These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38679166)

  • 21. Transplantation of hepatitis D virus patients: Lifelong hepatitis B immunoglobulins?
    Ferenci P; Reiberger T; Stadlbauer V; Zoller H
    Liver Int; 2023 Aug; 43 Suppl 1():96-100. PubMed ID: 35767373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B virus vaccination booster does not provide additional protection in adolescents: a cross-sectional school-based study.
    Chang YC; Wang JH; Chen YS; Lin JS; Cheng CF; Chu CH
    BMC Public Health; 2014 Sep; 14():991. PubMed ID: 25248369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistent Control of Hepatitis B Virus and Hepatitis Delta Virus Infection Following REP 2139-Ca and Pegylated Interferon Therapy in Chronic Hepatitis B Virus/Hepatitis Delta Virus Coinfection.
    Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Anderson M; Gersch J; Holzmayer V; Elsner C; Krawczyk A; Kuhns MC; Cloherty G; Dittmer U; Vaillant A
    Hepatol Commun; 2021 Feb; 5(2):189-202. PubMed ID: 33553968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seroprevalence of HBV (anti-HBc, HBsAg and anti-HBs) and HDV infections among 9006 women at delivery.
    Bart PA; Jacquier P; Zuber PL; Lavanchy D; Frei PC
    Liver; 1996 Apr; 16(2):110-6. PubMed ID: 8740844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Sero-epidemiological characteristics of the hepatitis D virus infection among hepatitis B virus infected-patients at a single center in Xinjiang region].
    Zheng RJ; Talafu T; Deng ZR; Han D; Pan KJ; Lu XB
    Zhonghua Gan Zang Bing Za Zhi; 2022 Oct; 30(10):1044-1049. PubMed ID: 36727249
    [No Abstract]   [Full Text] [Related]  

  • 26. Association of the interleukin-12 polymorphic variants with the development of antibodies to surface antigen of hepatitis B virus in hemodialysis patients in response to vaccination or infection.
    Grzegorzewska AE; Wobszal PM; Sowińska A; Mostowska A; Jagodziński PP
    Mol Biol Rep; 2013 Dec; 40(12):6899-911. PubMed ID: 24158609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
    Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
    Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Longitudinal Hepatitis B Vaccine Cohort Demonstrates Long-lasting Hepatitis B Virus (HBV) Cellular Immunity Despite Loss of Antibody Against HBV Surface Antigen.
    Simons BC; Spradling PR; Bruden DJ; Zanis C; Case S; Choromanski TL; Apodaca M; Brogdon HD; Dwyer G; Snowball M; Negus S; Bruce MG; Morishima C; Knall C; McMahon BJ
    J Infect Dis; 2016 Jul; 214(2):273-80. PubMed ID: 27056956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of surface antibody in hepatitis B reactivation in patients with resolved infection and hematologic malignancy: A meta-analysis.
    Paul S; Dickstein A; Saxena A; Terrin N; Viveiros K; Balk EM; Wong JB
    Hepatology; 2017 Aug; 66(2):379-388. PubMed ID: 28128861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Presence of Hepatitis B Surface Antibody in Addition to Hepatitis B Core Antibody Confers Protection Against Hepatitis B Virus Infection in Hepatitis B Surface Antigen-negative Patients Undergoing Kidney Transplantation.
    Jeon JW; Kim SM; Cho H; Baek CH; Kim H; Shin S; Kim YH; Han DJ; Kim SB
    Transplantation; 2018 Oct; 102(10):1717-1723. PubMed ID: 29621059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and detection of anti-HBs antibodies after hepatitis B virus infection or vaccination in the context of protective immunity.
    Pondé RAA
    Arch Virol; 2019 Nov; 164(11):2645-2658. PubMed ID: 31399876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seroepidemiology of hepatitis B virus, hepatitis D virus, and human immunodeficiency virus infections among parenteral drug abusers in southern Taiwan.
    Chung DC; Ko YC; Chen CJ; Chen ER; Wu CC; Wu PS
    J Med Virol; 1989 Aug; 28(4):215-8. PubMed ID: 2778445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis D Viremia Among Injection Drug Users in San Francisco.
    Mahale P; Aka PV; Chen X; Liu P; Fram BJ; Wang AS; Simenel S; Tseng FC; Chen S; Edlin BR; Glenn JS; O'Brien TR
    J Infect Dis; 2018 May; 217(12):1902-1906. PubMed ID: 29800369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver transplantation in HBs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunization.
    Müller R; Gubernatis G; Farle M; Niehoff G; Klein H; Wittekind C; Tusch G; Lautz HU; Böker K; Stangel W
    J Hepatol; 1991 Jul; 13(1):90-6. PubMed ID: 1918881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of antiviral - passive - active immunization ("sandwich") therapeutic strategy for functional cure of chronic hepatitis B in mice.
    Shi B; Wu Y; Wang C; Li X; Yu F; Wang B; Yang Z; Li J; Liang M; Wen Y; Ying T; Yuan Z
    EBioMedicine; 2019 Nov; 49():247-257. PubMed ID: 31680000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of anti-hepatitis B surface (HBs) antibodies after HBs antigen loss in HIV-hepatitis B virus co-infected patients.
    Boyd A; Canini L; Gozlan J; Lascoux-Combe C; Miailhes P; Fonquernie L; Girard PM; Lacombe K
    J Clin Virol; 2017 Oct; 95():55-60. PubMed ID: 28869890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of anti-HBs in hepatitis B reactivation during direct-acting antiviral therapy for chronic hepatitis C.
    Spaan M; Bruce M; Agarwal K; Carey I
    Antivir Ther; 2018; 23(6):539-542. PubMed ID: 30309997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis B and D virus infection among drug abusers in Taiwan.
    Lee SD; Wang JY; Wu JC; Chiang YT; Tsai YT; Lo KJ
    J Med Virol; 1986 Nov; 20(3):247-52. PubMed ID: 3783132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen.
    Cooreman MP; Leroux-Roels G; Paulij WP
    J Biomed Sci; 2001; 8(3):237-47. PubMed ID: 11385295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
    Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H
    J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.